TABLE 1.
Trends in MeSH terms over time
| Topic | 1980–1984 | 1985–1989 | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 |
|---|---|---|---|---|---|---|---|---|
| Prenatal Cytogenetics | 94% | 87% | 91% | 71% | 60% | 55% | 39% | 31% |
| Congenital Anomalies | 45% | 38% | 47% | 37% | 46% | 49% | 39% | 41% |
| Fetal Imaging | 22% | 22% | 24% | 29% | 33% | 35% | 30% | 18% |
| Single gene disorders | 29% | 30% | 28% | 19% | 16% | 14% | 9% | 8% |
| Serum Screening | 11% | 12% | 22% | 20% | 15% | 14% | 14% | 14% |
| Molecular Genetics | 2% | 8% | 11% | 15% | 14% | 16% | 15% | 19% |
| Blood | 15% | 10% | 6% | 10% | 7% | 7% | 4% | 2% |
| Maternal Health | 1% | 4% | 3% | 4% | 4% | 8% | 12% | 4% |
| Multiple Gestation | 8% | 3% | 7% | 4% | 4% | 9% | 7% | 4% |
| Placenta | 3% | 5% | 6% | 5% | 4% | 5% | 8% | 5% |
| Sex Chromosomes | 6% | 6% | 6% | 6% | 6% | 7% | 3% | 3% |
| NIPT | 0% | 0% | 0% | 0% | 0% | 2% | 7% | 18% |
| Fetal Therapy | 9% | 1% | 0% | 2% | 1% | 3% | 7% | 7% |
| Health Attitudes | 1% | 1% | 2% | 2% | 3% | 5% | 6% | 4% |
| Abortion | 5% | 5% | 5% | 2% | 3% | 5% | 4% | 3% |
| Genetic Counseling | 2% | 2% | 2% | 1% | 5% | 4% | 4% | 4% |
| Preimplantation Genetic Testing | 0% | 1% | 1% | 2% | 8% | 5% | 2% | 2% |
| Growth Restriction | 1% | 2% | 2% | 2% | 3% | 3% | 5% | 3% |
| Neoplasms | 5% | 3% | 5% | 2% | 3% | 2% | 2% | 1% |
| Infection | 0% | 1% | 3% | 3% | 2% | 2% | 2% | 1% |
| Enzyme | 15% | 9% | 4% | 2% | 2% | 0% | 0% | 0% |
The deepest shade of green is the highest value.
The lightest shade of green is the lowest value.
The midpoint is at the 70%.